COVID-19 bubble: Should you create a winter bubble or pod? today.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from today.com Daily Mail and Mail on Sunday newspapers.
Signet Engaged To Help Deliver Emory Proton Therapy Center In Atlanta
Share Article
Signet Real Estate Group will oversee delivery of a 112,500 square foot proton therapy facility to Emory University Hospital in Atlanta, the first of its kind in Georgia to offer this state-of-the-art cancer treatment technology. Atlanta, Georgia (PRWEB) December 16, 2020 Signet Real Estate Group has been engaged by the new owners of the Emory Proton Therapy Center, Provident Resources Group, to provide turn-key project management services for the project. Construction and equipment installation resumed last month and the Center is scheduled to begin treating cancer patients in the fall of 2018. The 112,500 square foot facility, located a few blocks away from Emory University Hospital in Midtown Atlanta, is the first of its kind in Georgia to offer this state-of-the-art cancer treatment technology.
Tags »
In a randomized, controlled trial of more than 1,000 adults hospitalized with COVID-19 pneumonia, treatment with the anti-inflammatory drug baricitinib resulted in faster recovery and a greater likelihood of clinical improvement, when combined with the antiviral drug remdesivir.
The results of the international ACTT-2 (Adaptive COVID-19 Treatment Trial), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, were published Friday Dec. 11 in the
Baricitinib was originally developed by Eli Lilly and Company for rheumatoid arthritis and was FDA-approved for that indication in 2017. The drug, part of a class of drugs that inhibits JAK enzymes, received an emergency use authorization for COVID-19 treatment in November 2020, based upon the ACTT-2 results.
Juan Anchondo, a medical-surgical nurse at Las Palmas Medical Center, in El Paso, Texas, says he s ready for a Covid-19 vaccine and more than ready for the pandemic to be over.
Aaron E. Martinez/El Paso Times
Now that the Pfizer-BioNTech coronavirus vaccine has been cleared for emergency use, frontline health care workers across the U.S. are days away from being offered the shots. They couldn’t be arriving at a more crucial moment, with Covid-19 cases at their highest level since the pandemic began a year ago and many hospitals overwhelmed.
With a second vaccine, Moderna’s, expected to be approved shortly, government officials have projected that 20 million people will be inoculated by the end of December, with health care workers and residents of long term care facilities first in line.